Benzinga | Oct 8, 2020 06:19AM EDT

JP Morgan Downgrades TransMedics Group to Neutral, Announces $15 Price Target

JP Morgan analyst Robert Marcus downgrades TransMedics Group (NASDAQ:TMDX) from Overweight to Neutral and announces $15 price target.